Interestingly, there was upregulation of ACE2 in epithelial cells in some COVID-19 patients with neurological involvement, particularly in the white matter and in patients with severe neurological symptoms (Lindskog et al., 2022). The gene discussed is ACE2; the disease is COVID-19.